Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lamivudine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Mylan Pharms Inc
LAMIVUDINE
lamivudine
TABLET;ORAL204002ANDAMylan Pharmaceuticals Inc.0378-5168-9330 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5168-93)
Glaxosmithkline
EPIVIR-HBV
lamivudine
TABLET;ORAL021003NDAGlaxoSmithKline LLC0173-0662-0060 TABLET, FILM COATED in 1 BOTTLE (0173-0662-00)
Glaxosmithkline
EPIVIR-HBV
lamivudine
TABLET;ORAL021003NDAState of Florida DOH Central Pharmacy53808-0893-130 TABLET, FILM COATED in 1 BLISTER PACK (53808-0893-1)
Glaxosmithkline
EPIVIR-HBV
lamivudine
TABLET;ORAL021003NDA AUTHORIZED GENERICPrasco Laboratories66993-478-6060 TABLET, FILM COATED in 1 BOTTLE (66993-478-60)
Glaxosmithkline
EPIVIR-HBV
lamivudine
SOLUTION;ORAL021004NDAGlaxoSmithKline LLC0173-0663-00240 mL in 1 BOTTLE (0173-0663-00)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot